V Wealth Advisors LLC Bristol Myers Squibb CO Transaction History

V Wealth Advisors LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$63.71 - $70.74 $2,484 - $2,758	39 Added 0.65%	6,039 $386,000
Q1 2023 May 02, 2023	BUY	$65.71 - $74.53 $44,485 - $50,456	677 Added 12.72%	6,000 $415,000
Q4 2022 Jan 20, 2023	BUY	$68.48 - $81.09 $17,941 - $21,245	262 Added 5.18%	5,323 $0
Q3 2022 Nov 04, 2022	BUY	$0.13 - $76.84 $0 - $153	2 Added 0.04%	5,061 $360,000
Q2 2022 Jul 27, 2022	BUY	$72.62 - $79.98 $21,422 - $23,594	295 Added 6.19%	5,059 $389,000
Q1 2022 May 16, 2022	SELL	$61.48 - $73.72 $53,610 - $64,283	-872 Reduced 15.47%	4,764 $348,000
Q4 2021 Feb 17, 2022	SELL	$53.63 - $62.52 $45,370 - $52,891	-846 Reduced 13.05%	5,636 $351,000
Q3 2021 Oct 21, 2021	BUY	$59.17 - $69.31 $53,726 - $62,933	908 Added 16.29%	6,482 $383,000
Q2 2021 Jul 27, 2021	BUY	$61.91 - $67.42 $1,981 - $2,157	32 Added 0.58%	5,574 $372,000
Q1 2021 Apr 20, 2021	BUY	$59.34 - $66.74 $11,274 - $12,680	190 Added 3.55%	5,542 $350,000
Q4 2020 Jan 25, 2021	BUY	$57.74 - $65.43 $309,024 - $350,181	5,352 New	5,352 $332,000
Q3 2020 Oct 13, 2020	SELL	$57.43 - $63.64 $272,849 - $302,353	-4,751 Closed	0 $0
Q2 2020 Jul 29, 2020	SELL	$54.82 - $64.09 $119,946 - $140,228	-2,188 Reduced 31.53%	4,751 $279,000
Q1 2020 May 12, 2020	BUY	$46.4 - $67.43 $89,088 - $129,465	1,920 Added 38.25%	6,939 $386,000
Q3 2019 Nov 14, 2019	BUY	$42.77 - $50.71 $13,558 - $16,075	317 Added 6.74%	5,019 $255,000
Q2 2019 Jul 29, 2019	BUY	$44.62 - $49.34 $209,803 - $231,996	4,702 New	4,702 $212,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of V Wealth Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on V Wealth Advisors LLC with notifications on news.